Geoffrey D. Chisholm

Changes in urinary cytokines and soluble intercellular adhesion molecule‐1 (ICAM‐1) in bladder cancer patients after Bacillus Calmette—Guérin (BCG) immunotherapy

S. Prescott, A. Jackson, K. James, 1995, Clinical and experimental immunology.

Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy.

J. Smyth, S. Prescott, K. James, 1990, The Journal of urology.

Cytokine modulation of epidermal growth factor receptor expression on bladder cancer cells is not a major contributor to the antitumour activity of cytokines.

A. Jackson, K. James, G. Chisholm, 1995, European journal of cancer.

Intra-epithelial lymphocytes in the normal epididymis. A mechanism for tolerance to sperm auto-antigens?

K. James, A. Ritchie, T. Hargreave, 1984, British journal of urology.

He sold his bike for a low prostate specific antigen.

G. Chisholm, A. Rana, Geoffrey D. Chisholm, 1994, The Journal of urology.

TNM (1978) in bladder cancer: use and abuse.

T. Hargreave, A. Howatson, G. Chisholm, 1980, British journal of urology.

Induction of ICAM 1 expression on bladder tumours by BCG immunotherapy.

A. Jackson, K. James, G. Chisholm, 1994, Journal of clinical pathology.

The inhibitory effects of interferon gamma on the growth of bladder cancer cells.

J. Smyth, S. Prescott, A. Jackson, 1992, The Journal of urology.